Abstract
Genetic mutations can cause specific changes to cardiomyopathy (CMP) phenotype, and these changes may be associated with a variety of abnormalities of different organs and systems. Therefore, the clinical approach is very important, as is the presence of “red flags”, which are potentially useful for better characterization of the genetic background of the CMP.
Keywords
- Muscular Dystrophy
- Cardiac Involvement
- Duchenne Muscular Dystrophy
- Myotonic Muscular Dystrophy
- Supraventricular Arrhythmia
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
McNally EM, MacLeod H (2005) Therapy insight: cardiovascular complications associated with muscular dystrophies. Nat Clin Pract Cardiovasc Med 2:301–308. doi:10.1038/ncpcar-dio0213
Taylor MR, Fain PR, Sinagra G et al (2003) Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol 41:771–780
Lapidos KA, Kakkar R, McNally EM (2004) The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ Res 94:1023–1031. doi:10.1161/01.RES.0000126574.61061.25
Brooke MH, Fenichel GM, Griggs RC et al (1989) Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology 39:475–481
Jefferies JL, Eidem BW, Belmont JW et al (2005) Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112:2799–2804. doi:10.1161/CIR-CULATIONAHA. 104.528281
Melacini P, Fanin M, Danieli GA et al (1996) Myocardial involvement is very frequent among patients affected with subclinical Becker’s muscular dystrophy. Circulation 94:3168–3175
Mestroni L, Miyamoto SD, Taylor MR (2007) Genetics of dilated cardiomyopathy conduction disease. Prog Pediatr Cardiol 24:3–13
Mirabella M, Servidei S, Manfredi G et al (1993) Cardiomyopathy may be the only clinical manifestation in female carriers of Duchenne muscular dystrophy. Neurology 43:2342–2345
Politano L, Nigro V, Nigro G et al (1996) Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA 275:1335–1338
Arbustini E, Diegoli M, Morbini P et al (2000) Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy. J Am Coll Cardiol 35:1760–1768
Tsubata S, Bowles KR, Vatta M et al (2000) Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 106:655–662. doi:10.1172/JCI9224
Sylvius N, Duboscq-Bidot L, Bouchier C et al (2003) Mutational analysis of the beta-and delta-sarcoglycan genes in a large number of patients with familial and sporadic dilated cardiomyopathy. Am J Med Genet A 120A:8–12. doi:10.1002/ajmg.a.20003
Barresi R, Di Blasi C, Negri T et al (2000) Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations. J Med Genet 37:102–107
Melacini P, Fanin M, Duggan DJ et al (1999) Heart involvement in muscular dystrophies due to sarcoglycan gene mutations. Muscle Nerve 22:473–479
Gerull B, Gramlich M, Atherton J et al (2002) Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 30:201–204. doi: 10.1038/ng815
Satoh M, Takahashi M, Sakamoto T et al (1999) Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem Biophys Res Commun 262:411–417. doi:10.1006/bbrc.1999.1221
Carmignac V, Salih MA, Quijano-Roy S et al (2007) C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy. Ann Neurol 61:340–351. doi:10.1002/ana.21089
Sylvius N, Tesson F (2006) Lamin A/C and cardiac diseases. Curr Opin Cardiol 21:159–165. doi:10.1097/01.hco.0000221575.33501.58
Karkkainen S, Helio T, Miettinen R et al (2004) A novel mutation, Ser143Pro, in the lamin A/C gene is common in Finnish patients with familial dilated cardiomyopathy. Eur Heart J 25:885–893.doi:10.1016/j.ehj.2004.01.020
Emery AE, Dreifuss FE (1966) Unusual type of benign x-linked muscular dystrophy. J Neurol Neurosurg Psychiatry 29:338–342
Bonne G, Di Barletta R, Varnous et al (1999) Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 21:285–288. doi: 10.1038/6799
Raffaele Di Barletta M, Ricci E et al (2000) Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am J Hum Genet 66:1407–1412. doi:10.1086/302869
Brodsky GL, Muntoni F, Miocic S et al (2000) Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 101:473–476
Fatkin D, MacRae C, Sasaki T et al (1999) Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 341:1715–1724. doi:10.1056/NEJM199912023412302
van der Kooi AJ, Bonne G, Eymard B et al (2002) Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy. Neurology 59:620–623
Caux F, Dubosclard E, Lascols O et al (2003) A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy. J Clin Endocrinol Metab 88:1006–1013
Sakata K, Shimizu M, Ino H et al (2005) High incidence of sudden cardiac death with conduction disturbances and atrial cardiomyopathy caused by a nonsense mutation in the STA gene. Circulation 111:3352–3358. doi:10.1161/CIRCULATIONAHA.104.527184
Yoshioka M, Saida K, Itagaki Y, Kamiya T (1989) Follow up study of cardiac involvement in Emery-Dreifuss muscular dystrophy. Arch Dis Child 64:713–715
Rees W, Schuler S, Hummel M, Hetzer R (1993) Heart transplantation in patients with muscular dystrophy associated with end-stage cardiomyopathy. J Heart Lung Transplant 12:804–807
Cartegni L, di Barletta MR, Barresi R et al (1997) Heart-specific localization of emerin: new insights into Emery-Dreifuss muscular dystrophy. Hum Mol Genet 6:2257–2264
Buckley AE, Dean J, Mahy IR (1999) Cardiac involvement in Emery Dreifuss muscular dystrophy: a case series. Heart 82:105–108
Murakami T, Hayashi YK, Noguchi S et al (2006) Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness. Ann Neurol 60:597–602. doi:10.1002/ana.20973
GeneTests: Medical Genetics Information Resource (1993–2010) University of Washington, Seattle. http://www.genetests.org. Accessed 8 May 2012
Miura K, Shirasawa H (1987) Congenital muscular dystrophy of the Fukuyama type (FCMD) with severe myocardial fibrosis. A case report with postmortem angiography. Acta Pathol Jpn 37:1823–1835
Osawa M, Arai Y, Ikenaka H et al (1991) Fukuyama type congenital progressive muscular dystrophy. Acta Paediatr Jpn 33:261–269
Groh WJ, Groh MR, Saha C et al (2008) Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 358:2688–2697. doi: 10.1056/NEJMoa062800
von zur Muhlen F, Klass C, Kreuzer H et al (1998) Cardiac involvement in proximal myotonic myopathy. Heart 79:619–621
Shen EN, Madsen T (1991) Facioscapulohumeral muscular dystrophy and recurrent pacemaker lead dislodgement. Am Heart J 122:1167–1169
Laforet P, de Toma C, Eymard B et al (1998) Cardiac involvement in genetically confirmed facioscapulohumeral muscular dystrophy. Neurology 51:1454–1456
Selcen D, Muntoni F, Burton BK et al (2009) Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann Neurol 65:83–89. doi:10.1002/ana.21553
Reilich P, Schoser B, Schramm N et al (2010) The p.G154S mutation of the alpha-B crystallin gene (CRYAB) causes late-onset distal myopathy. Neuromuscul Disord 20:255–259. doi:10.1016/j.nmd.2010.01.012
Dalakas MC, Park KY, Semino-Mora C et al (2000) Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med 342:770–780. doi:10.1056/NEJM200003163421104
Li D, Tapscoft T, Gonzalez O et al (1999) Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 100:461–464
Taylor MR, Slavov D, Ku L et al (2007) Prevalence of desmin mutations in dilated cardiomyopathy. Circulation 115:1244–1251. doi:10.1161/CIRCULATIONAHA.106.646778
Vatta M, Mohapatra B, Jimenez S et al (2003) Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 42:2014–2027
Arimura T, Hayashi T, Terada H et al (2004) A Cypher/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C. J Biol Chem 279:6746–6752. doi:10.1074/jbc.M311849200
Selcen D, Engel AG (2005) Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann Neurol 57:269–276. doi:10.1002/ana.20376
Hauser MA, Horrigan SK, Salmikangas P et al (2000) Myotilin is mutated in limb girdle muscular dystrophy 1A. Hum Mol Genet 9:2141–2147
Selcen D, Engel AG (2004) Mutations in myotilin cause myofibrillar myopathy. Neurology 62:1363–1371
Bagneris C, Bateman OA, Naylor CE et al (2009) Crystal structures of alpha-crystallin domain dimers of alphaB-crystallin and Hsp20. J Mol Biol 392:1242–1252. doi: 10.1016/j.jmb.2009.07.069
Wang X, Klevitsky R, Huang W et al (2003) AlphaB-crystallin modulates protein aggregation of abnormal desmin. Circ Res 93:998–1005. doi:10.1161/01.RES.0000102401.77712.ED
Pilotto A, Marziliano N, Pasotti M et al (2006) alphaB-crystallin mutation in dilated cardiomyopathies: low prevalence in a consecutive series of 200 unrelated probands. Biochem Biophys Res Commun 346:1115–1117. doi:10.1016/j.bbrc.2006.05.203
Sacconi S, Feasson L, Antoine JC et al (2012) A novel CRYAB mutation resulting in multisystemic disease. Neuromuscul Disord 22:66–72. doi:10.1016/j.nmd.2011.07.004
Fitzpatrick AP, Shapiro LM, Rickards AF et al (1990) Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy. Br Heart J 63:114–118
Katritsis D, Wilmshurst PT, Wendon JA et al (1991) Primary restrictive cardiomyopathy: clinical and pathologic characteristics. J Am Coll Cardiol 18:1230–1235
Ishiwata S, Nishiyama S, Seki A, Kojima S (1993) Restrictive cardiomyopathy with complete atrio ventricular block and distal myopathy with rimmed vacuoles. Jpn Circ J 57:928–933
Milasin J et al (1996) Apoint mutation in the 54 splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Human Molecular Genetics 5(1):73–79
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Italia
About this chapter
Cite this chapter
Sinagra, G., Camerini, F., Fabris, E. (2013). The Role of Clinical Observation: Red Flag 1 — Cardiomyopathies and Skeletal Muscle Involvement. In: Sinagra, G., Mestroni, L., Camerini, F. (eds) Genetic Cardiomyopathies. Springer, Milano. https://doi.org/10.1007/978-88-470-2757-2_3
Download citation
DOI: https://doi.org/10.1007/978-88-470-2757-2_3
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2756-5
Online ISBN: 978-88-470-2757-2
eBook Packages: MedicineMedicine (R0)